Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  anemia
Trial Type:  Supportive care
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-24 of 24 for your search:
Start Over
Phase IV Study of Epoetin alfa in Women With Stage I, II, or III Breast Cancer and Chemotherapy-Related Anemia. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information.
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0011004, ORTHO-PR-00-27-012, ORTHO-PR-01-27-003, NCI-G01-2002, NCT00022386
Phase III Randomized Study of Epoetin Alfa versus Placebo in Anemic Patients Receiving Chemotherapy for Stage IV Metastatic Breast Cancer (Summary Last Modified 02/1999)
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18-80
Sponsor: NCI
Protocol IDs: RPCI-DS-97-10, ORTHO-PR-96-27-004, NCI-G98-1394
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066673, NCCTG-979253, NCI-P98-0133, 97-92-53, NCT00003600
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9903, CDR0000067599, RTOG-DEV-1008, NCT00004917
Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: GOG-0191, NCI-2012-02384, CAN-NCIC-CX4, CDR0000068641, U10CA027469, CX4, NCT00017004
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000288821, NCCTG-N02C2, NCT00058331
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000301881, ECOG-E1Z01, E1Z01, NCT00060398
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000333213, P30CA016042, UCLA-0306021, AMGEN-20030125, NCT00070382
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000593480, P30CA015083, MC04CC, NCI-2009-01226, 1713-05, MAYO-MC04CC, NCT00661999
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065907, E1996, U10CA021115, ECOG-1996, NCT00003138
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069246, CALGB-10003, NCT00031980
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000350089, U10CA031946, CALGB-30303, NCT00077311
Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000449950, UCLA-0504038, ORTHO-PR04-27-018, NCT00255749
Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000522677, P30CA015083, RC05CB, 06-002991, EPOANE3015, MCCRC-RC05CB, MCCRC-06-002991, ORTHO-MCCRC-RC05CB, NCT00416624
Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue
Phase: Phase II
Type: Supportive care
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: NU 98CC7, NCI-G00-1706, NCT00004914
Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients With Myelofibrosis
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MC1283, NCI-2012-02201, P30CA015083, NCT01732445
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
Phase: No phase specified
Type: Supportive care, Treatment
Status: Completed
Age: 0.5 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000066589, J9711, P30CA006973, JHOC-97021903, JHOC-J9711, NCI-V98-1460, NCT00003538
Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CASE-CCF-5497, P30CA043703, ORTHO-CASE-CCF-5497, NCT00400686
Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CCCWFU 97710, NCI-2010-02228, NCT01273766
Start Over